Methods
A detailed account of the methods used in the Oxford-Family Planning Association study has been given elsewhere.' In brief, 17 032 women were recruited at 17 large family planning clinics in England and Scotland during 1968-74. At the time of recruitment, each of these women had to be: (a) aged 25-39 years, (b) married, (c) a white British subject, (d) willing to participate, and (e) either a current user of oral contraceptives with at least five months' use or a current user of a diaphragm or an intrauterine device with at least five months' use and without prior exposure to the pill. During follow-up each woman is questioned at return visits to the clinic by a doctor or nurse and certain items of information are noted on a special form, including details of pregnancies and their outcome, changes in contraceptive practice, and reasons for referral to hospital as an outpatient or inpatient. Women who stop attending the clinic are sent a postal version of the questionnaire and, if this is not returned, are interviewed on the telephone or at a home visit. The work in each clinic is co-ordinated by a part-time research assistant, and follow-up has been maintained with an annual loss rate for "relevant" reasons (withdrawal of co-operation or loss of contact) of only about 0.3%0.
The results presented here concern 72 women with histologically proved cancer of the breast first diagnosed during follow-up before 1 September 1980. The analysis of the data was based on the computation of woman-years of observation in the various groups compared. Breast-cancer incidence rates were standardised by the indirect method as described by Vessey et al.' Use of the pill before entry to the study was taken into account during the computation of breastcancer incidence rates in relation to total duration of oral contraceptive use and to interval since oral contraceptives were first used.
Results
Preliminary analysis showed the general pattern of occurrence of breast cancer in the Oxford-Family Planning Association study to be in accordance with the known epidemiology of the disease.' Thus the incidence rate per 1000 woman-years of observation rose from 0-22 in those aged 25-29 years to 1-05 in those aged 40 years or more, while the age-standardised incidence rates rose from 0-19 in those first giving birth at 20 years or less to 0-52 in those first giving birth at 26 years or more, from 0 43 in those with no history of benign disease of the breast to 1-75 in those with such a history, and from 0 47 in those from social classes IV and V to 0 62 in those from social classes I and II. No data were available about age at menarche or family history of breast cancer, and too few of the subjects had reached the menopause to justify examining the effect of the age at which it occurred.
The relation between various measures of oral-contraceptive use and the incidence of breast cancer is shown in the increased risk of breast cancer experienced by those with a history of benign breast disease, which is contrary to the findings of some recent reports.3 This association will be examined in detail when more data have accrued.
Discussion A detailed discussion of other studies concerned with the possible association between oral contraceptives and malignant disease of the breast has been given in the preceding paper. Our data add some weight to the view that the use of oral contraceptives does not increase the risk of breast cancer. In particular, at ages up to 34 years, where the findings in the RCGP study were slightly worrying (on the basis of 28 cases of cancer), our data show a modest negative association between pill use and malignant disease of the breast (on the basis of 14 cases of cancer).
Although our findings are reassuring, data about women with long exposure to the pill are few and information about any interaction between oral contraceptives and risk factors for breast cancer is limited. As we have pointed out before,5 it must also be remembered that over the years women have adopted the pill at younger and younger ages and have used oral contraceptives to delay the first birth as well as to space or limit later births. Data derived from women who, like those in this study, mostly started to use the pill in their 20s after giving birth to at least one child, may not be applicable to girls starting to use the preparations in their teens before their first pregnancy. 
